No Prescription |
 |
 | ||
|
Glucovance Generic Glyburide |
|
| ||
No Prescription » Prescription Drugs 8 » Glucovance Generic Glyburide This anti-diabetic medication is a combination of 2 drugs (glyburide and metformin). It is used along with a diet and exercise program to control high blood sugar in patients with type 2 diabetes (non-insulin-dependent diabetes).Glyburide is a sulfonylurea and works by stimulating the release of your body's natural insulin and by decreasing the amount of sugar that your liver makes. Metformin is a biguanide and works by decreasing the amount of sugar that your liver makes and that your stomach/intestines absorb. Both of these medications work by helping to restore your body's proper response to the insulin you naturally produce.Controlling high blood sugar helps prevent kidney damage blindness nerve problems loss of limbs and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Buy Glucovance Generic Glyburide and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Glucovance Generic Glyburide: Product Type: Prescription Drugs 8 Glucovance ( Generic Glyburide/Metformin ) Glucovance (Generic Glyburide/Metformin) Generic Glyburide/Metformin 2.5/500mg 30 Tablets 2.5/500mg 90 Tablets 2.5/500mg 180 Tablets 5/500mg 30 Tablets 5/500mg 180 Tablets 5/500mg 90 Tablets Generic Glyburide/Metformin Glucovance
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
